Investor Says K-V Lied About Pregnancy Drug's Prospects
Frank Julianello claims the company violated the anti-fraud provisions of federal securities laws by promoting to investors its new Makena Care Connection program while at the same time increasing the price of the drug so high that physicians refused to prescribe it.
Julianello says K-V pinned...
Already a subscriber? Click here to login